Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood

L. S. Young, R. Bye, M. Scheltinga, T. R. Ziegler, Danny Jacobs, D. W. Wilmore

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Nutritional effects have traditionally focused on outcomes, such as nitrogen balance, wound healing, or muscle strength. Little emphasis has been placed on how biochemical or physical improvements translate into functional changes as perceived by the patient. Because glutamine (GLN)-supplemented nutrition promotes protein synthesis and improves nitrogen balance, we assessed the mood of individuals participating in a randomized controlled blinded trial receiving GLN solutions. Patients (n = 23) undergoing marrow transplantation were randomized by the research pharmacist to receive either standard total parenteral nutrition (TPN) (control) or GLN containing TPN (40 g of glutamine total). The solutions were isocaloric and isonitrogenous and were administered until the patient was eating 50% of estimated requirements. Before TPN and on admission to the hospital, the patient completed the Profile of Mood States questionnaire, a standardized test quantifying the degree of tension, depression, anger, vigor, fatigue, and confusion. The patient completed the questionnaire again at the end of TPN near discharge. The tests were scored and the change from baseline for each mood for both groups of patients was calculated at the completion of TPN. The scores for vigor in the control group (Δ scores) decreased over the course of hospitalization as would be expected with a serious illness. The group receiving glutamine TPN, however, essentially, showed little change in vigor from baseline and the Δ score was significantly different, from the control group (Δ vigor score -0.85 ± 2.1 in the glutamine group vs -5.90 ± 1.7 in the control groups p = .07). The control group exhibited little change in feelings of anger over the course of hospitalization; however, the glutamine TPN group felt significantly less angry at the completion of TPN than the control group (Δ anger score -6.2 ± 1.6 in the glutamine group vs -0.5 ± 2.5 in the control group; p = .052). There was a trend for the total mood score (all six moods evaluated together) to exhibit improvement (p = 1). The GLN group also was discharged from the hospital sooner and had fewer infectious episodes. This is one of the first studies to illustrate an improvement in patients' psychosocial status associated with a nutrition intervention. GLN may influence patients' feelings of well-being either directly by affecting central nervous system neurotransmitters or through its effects on the protein status of patients. Psychosocial testing may prove useful in evaluating the functional status of patients receiving nutrition support.

Original languageEnglish (US)
Pages (from-to)422-427
Number of pages6
JournalJournal of Parenteral and Enteral Nutrition
Volume17
Issue number5
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Parenteral Nutrition
Glutamine
Total Parenteral Nutrition
Control Groups
Anger
Emotions
Hospitalization
Nitrogen
Confusion
Muscle Strength
Pharmacists
Wound Healing
Fatigue
Neurotransmitter Agents
Proteins
Central Nervous System
Randomized Controlled Trials
Eating
Transplantation
Bone Marrow

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood. / Young, L. S.; Bye, R.; Scheltinga, M.; Ziegler, T. R.; Jacobs, Danny; Wilmore, D. W.

In: Journal of Parenteral and Enteral Nutrition, Vol. 17, No. 5, 01.01.1993, p. 422-427.

Research output: Contribution to journalArticle

Young, L. S. ; Bye, R. ; Scheltinga, M. ; Ziegler, T. R. ; Jacobs, Danny ; Wilmore, D. W. / Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood. In: Journal of Parenteral and Enteral Nutrition. 1993 ; Vol. 17, No. 5. pp. 422-427.
@article{08775488802a4c41a3b32f4709cf031e,
title = "Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood",
abstract = "Nutritional effects have traditionally focused on outcomes, such as nitrogen balance, wound healing, or muscle strength. Little emphasis has been placed on how biochemical or physical improvements translate into functional changes as perceived by the patient. Because glutamine (GLN)-supplemented nutrition promotes protein synthesis and improves nitrogen balance, we assessed the mood of individuals participating in a randomized controlled blinded trial receiving GLN solutions. Patients (n = 23) undergoing marrow transplantation were randomized by the research pharmacist to receive either standard total parenteral nutrition (TPN) (control) or GLN containing TPN (40 g of glutamine total). The solutions were isocaloric and isonitrogenous and were administered until the patient was eating 50{\%} of estimated requirements. Before TPN and on admission to the hospital, the patient completed the Profile of Mood States questionnaire, a standardized test quantifying the degree of tension, depression, anger, vigor, fatigue, and confusion. The patient completed the questionnaire again at the end of TPN near discharge. The tests were scored and the change from baseline for each mood for both groups of patients was calculated at the completion of TPN. The scores for vigor in the control group (Δ scores) decreased over the course of hospitalization as would be expected with a serious illness. The group receiving glutamine TPN, however, essentially, showed little change in vigor from baseline and the Δ score was significantly different, from the control group (Δ vigor score -0.85 ± 2.1 in the glutamine group vs -5.90 ± 1.7 in the control groups p = .07). The control group exhibited little change in feelings of anger over the course of hospitalization; however, the glutamine TPN group felt significantly less angry at the completion of TPN than the control group (Δ anger score -6.2 ± 1.6 in the glutamine group vs -0.5 ± 2.5 in the control group; p = .052). There was a trend for the total mood score (all six moods evaluated together) to exhibit improvement (p = 1). The GLN group also was discharged from the hospital sooner and had fewer infectious episodes. This is one of the first studies to illustrate an improvement in patients' psychosocial status associated with a nutrition intervention. GLN may influence patients' feelings of well-being either directly by affecting central nervous system neurotransmitters or through its effects on the protein status of patients. Psychosocial testing may prove useful in evaluating the functional status of patients receiving nutrition support.",
author = "Young, {L. S.} and R. Bye and M. Scheltinga and Ziegler, {T. R.} and Danny Jacobs and Wilmore, {D. W.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1177/0148607193017005422",
language = "English (US)",
volume = "17",
pages = "422--427",
journal = "Journal of Parenteral and Enteral Nutrition",
issn = "0148-6071",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Patients receiving glutamine-supplemented intravenous feedings report an improvement in mood

AU - Young, L. S.

AU - Bye, R.

AU - Scheltinga, M.

AU - Ziegler, T. R.

AU - Jacobs, Danny

AU - Wilmore, D. W.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Nutritional effects have traditionally focused on outcomes, such as nitrogen balance, wound healing, or muscle strength. Little emphasis has been placed on how biochemical or physical improvements translate into functional changes as perceived by the patient. Because glutamine (GLN)-supplemented nutrition promotes protein synthesis and improves nitrogen balance, we assessed the mood of individuals participating in a randomized controlled blinded trial receiving GLN solutions. Patients (n = 23) undergoing marrow transplantation were randomized by the research pharmacist to receive either standard total parenteral nutrition (TPN) (control) or GLN containing TPN (40 g of glutamine total). The solutions were isocaloric and isonitrogenous and were administered until the patient was eating 50% of estimated requirements. Before TPN and on admission to the hospital, the patient completed the Profile of Mood States questionnaire, a standardized test quantifying the degree of tension, depression, anger, vigor, fatigue, and confusion. The patient completed the questionnaire again at the end of TPN near discharge. The tests were scored and the change from baseline for each mood for both groups of patients was calculated at the completion of TPN. The scores for vigor in the control group (Δ scores) decreased over the course of hospitalization as would be expected with a serious illness. The group receiving glutamine TPN, however, essentially, showed little change in vigor from baseline and the Δ score was significantly different, from the control group (Δ vigor score -0.85 ± 2.1 in the glutamine group vs -5.90 ± 1.7 in the control groups p = .07). The control group exhibited little change in feelings of anger over the course of hospitalization; however, the glutamine TPN group felt significantly less angry at the completion of TPN than the control group (Δ anger score -6.2 ± 1.6 in the glutamine group vs -0.5 ± 2.5 in the control group; p = .052). There was a trend for the total mood score (all six moods evaluated together) to exhibit improvement (p = 1). The GLN group also was discharged from the hospital sooner and had fewer infectious episodes. This is one of the first studies to illustrate an improvement in patients' psychosocial status associated with a nutrition intervention. GLN may influence patients' feelings of well-being either directly by affecting central nervous system neurotransmitters or through its effects on the protein status of patients. Psychosocial testing may prove useful in evaluating the functional status of patients receiving nutrition support.

AB - Nutritional effects have traditionally focused on outcomes, such as nitrogen balance, wound healing, or muscle strength. Little emphasis has been placed on how biochemical or physical improvements translate into functional changes as perceived by the patient. Because glutamine (GLN)-supplemented nutrition promotes protein synthesis and improves nitrogen balance, we assessed the mood of individuals participating in a randomized controlled blinded trial receiving GLN solutions. Patients (n = 23) undergoing marrow transplantation were randomized by the research pharmacist to receive either standard total parenteral nutrition (TPN) (control) or GLN containing TPN (40 g of glutamine total). The solutions were isocaloric and isonitrogenous and were administered until the patient was eating 50% of estimated requirements. Before TPN and on admission to the hospital, the patient completed the Profile of Mood States questionnaire, a standardized test quantifying the degree of tension, depression, anger, vigor, fatigue, and confusion. The patient completed the questionnaire again at the end of TPN near discharge. The tests were scored and the change from baseline for each mood for both groups of patients was calculated at the completion of TPN. The scores for vigor in the control group (Δ scores) decreased over the course of hospitalization as would be expected with a serious illness. The group receiving glutamine TPN, however, essentially, showed little change in vigor from baseline and the Δ score was significantly different, from the control group (Δ vigor score -0.85 ± 2.1 in the glutamine group vs -5.90 ± 1.7 in the control groups p = .07). The control group exhibited little change in feelings of anger over the course of hospitalization; however, the glutamine TPN group felt significantly less angry at the completion of TPN than the control group (Δ anger score -6.2 ± 1.6 in the glutamine group vs -0.5 ± 2.5 in the control group; p = .052). There was a trend for the total mood score (all six moods evaluated together) to exhibit improvement (p = 1). The GLN group also was discharged from the hospital sooner and had fewer infectious episodes. This is one of the first studies to illustrate an improvement in patients' psychosocial status associated with a nutrition intervention. GLN may influence patients' feelings of well-being either directly by affecting central nervous system neurotransmitters or through its effects on the protein status of patients. Psychosocial testing may prove useful in evaluating the functional status of patients receiving nutrition support.

UR - http://www.scopus.com/inward/record.url?scp=0027306754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027306754&partnerID=8YFLogxK

U2 - 10.1177/0148607193017005422

DO - 10.1177/0148607193017005422

M3 - Article

VL - 17

SP - 422

EP - 427

JO - Journal of Parenteral and Enteral Nutrition

JF - Journal of Parenteral and Enteral Nutrition

SN - 0148-6071

IS - 5

ER -